A Cliniclal Study to find out the safest calcium supplement in calcium kidney stone formers

Not Applicable

• Conditions: Health Condition 1: N202- Calculus of kidney with calculus of ureter

• Registration Number: CTRI/2019/04/018531
• Lead Sponsor: State Board of Medical Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Patients who have been diagnosed as having calcium oxalate urinary stones

2.Between 15-65 years of age

3.With body mass index (BMI) between 18 and 30 kg/m2

4.willing to adhere to a low calcium diet for the duration of study (about 15 days)

Exclusion Criteria

1.Patients with Obstructive Uropathy, Chronic Urosepsis / Positive Urine Culture, Renal failure, (S. Creatinine > 2.0 mg %) Renal Tubular Acidosis, Primary Hyperoxaluria, Medullary Sponge Kidney.

2.Patients with anatomical abnormalities of the Urinary Tracts

3.Have a serious alternate disease that might affect completion of the study or jeopardize the study, like a known medical history of calcium or vitamin D malabsorption, leading to hypercalcemia and hypercalciuria, any current or recent diagnosis thought to affect bone or mineral metabolism or parameters related to calcium bioavailability such as hypo- or hyperparathyroidism, hypothyroidism, dyslipidemia, liver disease, or diabetes mellitus.

4.Patients taking any medications like corticosteroids or proton pump inhibitors had any clinically significant illness within 30 days of the start of the study,

5.Pregnancy

6.Active cancer

7.Recurrent urinary infections

8.Gross hematuria

9.Receiving treatment with thiazides (or alternatively can be enrolled if the patient is willing to stop treatment for 2 weeks prior to study)

10.Inability to give informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified